US Diabetes Devices Market size was valued at USD 6.8 Billion in 2024 and is expected to reach USD 19.8 Billion by 2033, at a CAGR of 7.3% during the forecast period 2024 – 2033.

US Diabetes Devices Market: Overview

Glucose monitoring systems, such as glucometers, help individuals measure their blood sugar levels, while CGM systems provide continuous real-time glucose readings, offering valuable insights into glucose trends and patterns. Insulin delivery devices, such as insulin pumps, pens, and syringes, enable precise administration of insulin doses to regulate blood sugar levels.

In the US, the diabetes device market is witnessing several prominent trends that are reshaping how diabetes is managed. Firstly, there’s a notable shift towards greater integration and connectivity in diabetes devices, driven by advancements in digital health technologies.

This includes the rise of continuous glucose monitoring (CGM) systems and insulin pumps with smartphone connectivity, allowing for real-time data monitoring and remote patient management. Secondly, there’s a growing emphasis on user-friendly and discreet designs, catering to the preferences and lifestyle needs of individuals with diabetes.

Get Free Sample Copy @ https://www.custommarketinsights.com/request-for-free-sample/?reportid=50451

Additionally, there’s increasing interest in the development of closed-loop systems or artificial pancreas technologies, aiming to automate insulin delivery and optimize blood glucose control.

Furthermore, there’s a trend towards personalized medicine, with the integration of data analytics and artificial intelligence to tailor diabetes management strategies to individual patient characteristics, leading to more precise and effective treatment outcomes.

By type, the insulin delivery devices segment held the highest market share in 2023 and is expected to keep its dominance during the forecast period 2024-2033. The trend in insulin delivery devices is towards increased convenience, accuracy, and integration of technology.

CMI has comprehensively analyzed US Diabetes Devices market. The driving forces, restraints, challenges, opportunities, key trends have been explained in depth to depict in depth scenario of market. Segment wise market size and market share during the forecast period is duly addressed to portray the probable picture of this US Diabetes Devices  industry.

The competitive landscape includes of key innovators, after market service providers, market giants as well as niche players are studied and analyzed extensively with respect to their strengths, weaknesses as well as value addition prospects. In addition, this report covers key players profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends and dynamics in partnerships.

List of the prominent players in the US Diabetes Devices Market:

  • Medtronic
  • Roche
  • Johnson & Johnson
  • Abbott Laboratories
  • Becton Dickinson and Company
  • Novo Nordisk
  • Dexcom
  • Sanofi
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings AG
  • Ypsomed Holding AG
  • Eli Lilly and Company
  • LifeScan
  • Tandem Diabetes Care
  • Terumo Corporation
  • Arkray
  • Senseonics Holdings Inc.
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Sinocare Inc.
  • AgaMatrix Holdings LLC
  • Trividia Health Inc.
  • Others

Table of Contents: https://www.custommarketinsights.com/report/us-diabetes-devices-market/#table-of-contents

About Us:

Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains.

Custom Market Insights provides a one-stop solution for data collection to investment advice. The expert analysis of our company digs out essential factors that help to understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation fall, forecasting or opportunity to grow, and consumer survey.

Contact Us:

USA Corporate Office

CMI Consulting LLC

1333, 701 Tillery Street Unit 12, Austin, TX, Travis, US, 78702
Sales & Support +1 801 639 9061

Email : support@custommarketinsights.com

Website : https://www.custommarketinsights.com/